Stay updated on Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial

Sign up to get notified when there's something new on the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Version history shows a new Revision: v3.4.2 added, and the funding-status notice along with Revision: v3.4.1 removed. These changes are limited to system-wide versioning and notices and do not modify study data or record content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T02:07:37.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about potential data delays due to government funding issues and updated the page version to v3.4.1. Removed the previous v3.4.0.
    Difference
    0.6%
    Check dated 2026-02-03T23:48:05.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Glossary toggle is now shown and the history uses green highlights for additions and red for deletions, along with a visible Revision: v3.4.0 label. A No FEAR Act Data item was added to the page.
    Difference
    1%
    Check dated 2026-01-27T23:53:05.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The history shows an added revision (v3.3.4) and a removal of revision v3.3.3, which is a minor update to the History page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T00:37:21.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2026-01-06T16:35:30.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    A new revision entry (Revision: v3.3.3) was added to the history, and the HHS Vulnerability Disclosure link along with Revision: v3.3.2 were removed from the footer.
    Difference
    0.2%
    Check dated 2025-12-23T08:11:14.000Z thumbnail image

Stay in the know with updates to Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page.